<DOC>
	<DOCNO>NCT00791934</DOCNO>
	<brief_summary>Study Design : A non-randomized , multi-center , prospective , clinical study intend evaluate safety efficacy treat ethmoid sinus Ethmoid Sinus Spacer Access System use local delivery Triamcinolone Acetonide , period 28 day .</brief_summary>
	<brief_title>Clinical Study Safety Efficacy Relieva Stratus With Elution Triamcinolone Acetonide</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Male female subject age 17 year old Radiographic evidence ethmoid disease ( baseline CT scan obtain within 30 day schedule surgery ) Diagnosis chronic sinusitis fail medical management ( minimum 3 week antibiotic ) Age &lt; 17 year old History glaucoma diagnosis glaucoma ( baseline visual exam indicate IOP &gt; 21 mmHg ) Adequate anatomical distance treatment Patient receive oral steroid treatment within two week prior day surgery Radiographic evidence extensive sinonasal osteoneogenesis could prevent device placement Sinonasal tumor obstructive lesion History facial trauma distorts sinus anatomy precludes access ethmoid sinus Contracted/underdeveloped ethmoid sinus Dehiscent lamina orbitalis Previous ethmoid surgery Ethmoid mucocele Extensive Nasal Polyps Asthmatic patient aspirin sensitivity Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>